Core Insights - The eighth China International Import Expo (CIIE) is being held from November 5 to 10 in Shanghai, where Abbott showcases multiple new products from its FreeStyle family, including the only integrated continuous glucose monitoring system (iCGM) certified by international standards in the Chinese market [1] - Abbott aims to promote standardized development in the industry by releasing several expert consensus documents during the expo, focusing on key scenarios such as blood glucose management for cardiovascular patients and perioperative care [1][2] Group 1 - Abbott's FreeStyle Libre Select sensor and FreeStyle Libre 2 Plus sensor meet the strictest international accuracy standards for iCGM and are compatible with various digital devices, enhancing convenience for users [1] - The upcoming LibreView software is designed for diabetes patients and healthcare professionals, allowing real-time remote monitoring and automatic report generation [1] Group 2 - The "Expert Consensus on Blood Glucose Variability Management in Cardiovascular Disease Patients" is the first of its kind in China, aimed at encouraging cardiovascular doctors to actively manage blood glucose variability using intuitive indicators like Time in Range (TIR) [2] - The "Standard for the Construction of Perioperative CGM Centers" emphasizes the importance of continuous glucose monitoring (CGM) in managing blood glucose levels during surgery, which is crucial for preventing hidden hyperglycemia and hypoglycemia, ensuring surgical safety, and promoting postoperative recovery [2]